#Other Patient ID	Patient Identifier	Form completion date	Neoplasm Histologic Type Name	Nodal anatomic site	Extranodal disease involvement site	Lymphomatous Extranodal Site Involvement Indicator	Percentage of follicular component	HIV Status	Prior Cancer Diagnosis Occurence	Neoadjuvant Therapy Type Administered Prior To Resection Text	Tissue Prospective Collection Indicator	Tissue Retrospective Collection Indicator	Sex	Race Category	Ethnicity Category	Patient Weight	Patient Height	Tumor resected max dimension	Year Cancer Initial Diagnosis	American Joint Committee on Cancer Publication Version Type	Neoplasm Disease Stage American Joint Committee on Cancer Code	Extranodal involvement	Performance Status	Idh level	Ldh upper limit	Person Neoplasm Status	Bone Marrow Biopsy Performed	Bone Marrow Involvement	Bone Marrow Sample Histology	Immunophenotypic analysis test	Immunophenotypic analysis methodology	Result of immunophenotypic analysis	Mib1 positive percentage range	B Cell Genotype Method	Igh genotype results	Igk genotype results	Genetic abnormality tested	Other genetic abnormality tested	Abnormality tested methodology	Abnormality tested results	Prior immunologic disease type	Prior immunologic disease other	Prior immunosuppressive therapy type	Prior infectious disease other	Prior infectious disease	Prior immunosuppressive therapy other	EBV Status	EBV Positive Malignant Cells Percent	EBV Status Malignant Cells Method	Did patient start adjuvant postoperative radiotherapy?	Adjuvant Postoperative Pharmaceutical Therapy Administered Indicator	Primary Therapy Outcome Success Type	New Neoplasm Event Post Initial Therapy Indicator	Diagnosis Age	Neoplasm American Joint Committee on Cancer Clinical Distant Metastasis M Stage	Neoplasm American Joint Committee on Cancer Clinical Regional Lymph Node N Stage	Neoplasm American Joint Committee on Cancer Clinical Primary Tumor T Stage	Neoplasm American Joint Committee on Cancer Clinical Group Stage	Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value	Disease code	ICD-10 Classification	International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code	International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code	Informed consent verified	Initial pathologic diagnosis method	Maximum tumor bulk anatomic location	Number of lymphnodes positive by ihc	American Joint Committee on Cancer Metastasis Stage Code	Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code	American Joint Committee on Cancer Tumor Stage Code	Lymph node location positive pathology name	Project code	Stage Other	Adjuvant Postoperative Targeted Therapy Administered Indicator	Tissue Source Site	Tumor Tissue Site	Overall Survival Status	Overall Survival (Months)	Disease Free Status	Disease Free (Months)
#Legacy DMP patient identifier (DMPnnnn)	Identifier to uniquely specify a patient.	Form completion date	Text term for the structural pattern of cancer cells used to define a microscopic diagnosis.	Nodal anatomic site	Extranodal disease involvement site	Indicator that identifies whether a patient with malignant lymphoma has lymphomatous involvement of an extranodal site.	Percentage of follicular component	HIV Status	Text term to describe the patient's history of prior cancer diagnosis and the spatial location of any previous cancer occurrence.	Text term to describe the patient's history of neoadjuvant treatment and the kind of treament given prior to resection of the tumor.	Text indicator for the time frame of tissue procurement, indicating that the tissue was procured in parallel to the project.	Text indicator for the time frame of tissue procurement, indicating that the tissue was obtained and stored prior to the initiation of the project.	Sex	The text for reporting information about race.	The text for reporting information about ethnicity.	Weight measured in kilograms.	Height in centimeters.	Tumor resected max dimension	Numeric value to represent the year of an individual's initial pathologic diagnosis of cancer.	The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.	The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.	Extranodal involvement	The functional level of the patient based on the Zubrod performance scale.	Idh level	Ldh upper limit	The state or condition of an individual's neoplasm at a particular point in time.	Bone Marrow Biopsy Performed	Bone Marrow Involvement	Bone Marrow Sample Histology	Immunophenotypic analysis test	Immunophenotypic analysis methodology	Result of immunophenotypic analysis	Mib1 positive percentage range	B Cell Genotype Method	Igh genotype results	Igk genotype results	Genetic abnormality tested	Other genetic abnormality tested	Abnormality tested methodology	Abnormality tested results	Prior immunologic disease type	Prior immunologic disease other	Prior immunosuppressive therapy type	Prior infectious disease other	Prior infectious disease	Prior immunosuppressive therapy other	Epstein-Barr Virus (EBV) Status	EBV Positive Malignant Cells Percent	EBV Status Malignant Cells Method	A yes/no indicator that asks whether the patient started adjuvant postoperative radiotherapy.	Indicator to signify whether or not whether the patient had adjuvant/post-operative pharmaceutical therapy.	Text term for the measure of success of outcome after primary treatment (surgery and adjuvant therapies).	Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.	Age at which a condition or disease was first diagnosed.	Extent of the distant metastasis for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.	Extent of the regional lymph node involvement for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.	Extent of the primary cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.	Stage group determined from clinical information on the tumor (T), regional node (N) and metastases (M) and by grouping cases with similar prognosis for cancer.	Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.	Disease code	10th revision of the International Statistical Classification of Diseases and Related Health Problems.	The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.	The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.	Informed consent verified	Initial pathologic diagnosis method	Maximum tumor bulk anatomic location	Number of lymphnodes positive by ihc	Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).	The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.	Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).	Lymph node location positive pathology name	Project code	Stage Other	Text term to signify postoperative adjuvant cancer therapies which use drugs to act upon specific molecules, metabolic pathways or processes involved in carcinogenesis, tumor growth, or tumor spread. [Manually-curated]	A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.	Text term that describes the anatomic site of the tumor or disease.	Overall patient survival status.	Overall survival in months since initial diagonosis.	Disease free status since initial diagnosis.	Disease free (months) since initial diagnosis.
#STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	NUMBER	NUMBER	NUMBER	NUMBER	STRING	STRING	STRING	NUMBER	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	NUMBER	STRING	STRING	STRING	STRING	STRING	NUMBER	STRING	STRING	STRING	STRING	NUMBER	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	NUMBER	STRING	NUMBER
#1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
OTHER_PATIENT_ID	PATIENT_ID	FORM_COMPLETION_DATE	HISTOLOGICAL_DIAGNOSIS	LYMPH_NODE_INVOLVEMENT_SITE	EXTRANODAL_INVOLVMENT_OTHER	EXTRANODAL_INVOLVEMENT	FOLLICULAR_COMPONENT_PERCENT	HIV_STATUS	HISTORY_OTHER_MALIGNANCY	HISTORY_NEOADJUVANT_TRTYN	PROSPECTIVE_COLLECTION	RETROSPECTIVE_COLLECTION	SEX	RACE	ETHNICITY	WEIGHT	HEIGHT	TUMOR_RESECTED_MAX_DIMENSION	INITIAL_PATHOLOGIC_DX_YEAR	AJCC_STAGING_EDITION	AJCC_PATHOLOGIC_TUMOR_STAGE	EXTRANODAL_LYMPHOMATOUS_INVOLVEMENT	ECOG_SCORE	IDH_LEVEL	LDH_NORM_RANGE_UPPER	TUMOR_STATUS	BONE_MARROW_BIOPSY_PERFORMED	BONE_MARROW_INVOLVEMENT	BONE_MARROW_SAMPLE_HISTOLOGY	IMMUNOPHENOTYPIC_ANALYSIS_TESTED	IMMUNOPHENOTYPIC_ANALYSIS_METHOD	IMMUNOPHENOTYPIC_ANALYSIS_RESULTS	MIB_1_POSITIVE_PERCENT_RANGE	B_CELL_GENOTYPE_METHOD	IGH_GENOTYPE_RESULT	IGK_GENOTYPE_RESULT	GENETIC_ABNORMALITY_TESTED	GENETIC_ABNORMALITY_TESTED_OTHER	GENETIC_ABNORMALITY_METHOD_OTHER	GENETIC_ABNORMALITY_RESULTS	HISTORY_IMMUNOLOGICAL_DISEASE	HISTORY_IMMUNOLOGICAL_DISEASE_OTHER	HISTORY_IMMUNOSUPPRESIVE_DX	HISTORY_IMMUNOSUPPRESSIVE_TX_OTHER	HISTORY_RELEVANT_INFECTIOUS_DX	HISTORY_IMMUNOSUPPRESIVE_DX_OTHER	EBV_STATUS	EBV_POSITIVE_MALIGNANT_CELLS_PERCENT	EBV_STATUS_MALIGNANT_CELLS_METHOD	RADIATION_TREATMENT_ADJUVANT	PHARMACEUTICAL_TX_ADJUVANT	TREATMENT_OUTCOME_FIRST_COURSE	NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT	AGE	CLIN_M_STAGE	CLIN_N_STAGE	CLIN_T_STAGE	CLINICAL_STAGE	DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS	DISEASE_CODE	ICD_10	ICD_O_3_HISTOLOGY	ICD_O_3_SITE	INFORMED_CONSENT_VERIFIED	INITIAL_PATHOLOGIC_DIAGNOSIS_METHOD	MAXIMUM_TUMOR_BULK_ANATOMIC_SITE	NUMBER_OF_LYMPHNODES_POSITIVE_BY_IHC	PATH_M_STAGE	PATH_N_STAGE	PATH_T_STAGE	POS_LYMPH_NODE_LOCATION	PROJECT_CODE	STAGE_OTHER	TARGETED_MOLECULAR_THERAPY	TISSUE_SOURCE_SITE	SITE_OF_TUMOR_TISSUE	OS_STATUS	OS_MONTHS	DFS_STATUS	DFS_MONTHS
a43e5f0e-a21f-48d8-97e0-084d413680b7	TCGA-FA-8693	9/12/12	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	[Not Available]	[Not Available]	1	< or = 10%	Negative	No	No	YES	NO	Male	WHITE	NOT HISPANIC OR LATINO	82.0	169.0	[Not Available]	2012	7th	[Not Applicable]	YES	[Not Available]	[Not Available]	[Not Available]	TUMOR FREE	[Not Available]	[Not Available]	[Not Available]	CD10 > 30%|CD20|CD5|Cyclin D1	Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry	Negative|Positive|Negative|Negative	51 - 75%	[Not Available]	[Not Evaluated]	[Not Evaluated]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Unknown]	[Not Available]	None	[Not Available]	[Not Available]	[Not Available]	[Not Evaluated]	[Not Available]	[Not Available]	[Unknown]	[Not Available]	[Not Applicable]	[Unknown]	75	[Not Applicable]	[Not Applicable]	[Not Applicable]	Stage I	0	[Not Available]	C83.3	9680/3	C16.9	YES	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Unknown]	FA	Stomach	0:LIVING	4.34	0:DiseaseFree	4.34
1843C82E-7A35-474F-9F79-C0A9AF9AA09C	TCGA-FA-A4BB	2/11/13	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	Axillary|Inguinal	Spleen	2	< or = 10%	Negative	No	No	YES	NO	Male	WHITE	NOT HISPANIC OR LATINO	85.0	178.0	3.5	2012	7th	[Not Applicable]	YES	[Not Available]	[Not Available]	[Not Available]	WITH TUMOR	NO	NO	[Not Available]	CD20|CD30	Immunohistochemistry|Immunohistochemistry	Positive|Positive	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	None	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	67	[Not Applicable]	[Not Applicable]	[Not Applicable]	Stage IV	0	[Not Available]	C83.3	9680/3	C77.3	YES	[Not Available]	Axillary lymph nodes	[Not Available]	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	FA	Liver|Other Extranodal Site	0:LIVING	4.34	0:DiseaseFree	4.34
A5B188F0-A6D3-4D4A-B04F-36D47EC05338	TCGA-FA-A4XK	3/22/13	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	other	[Not Available]	1	< or = 10%	Negative	No	No	YES	NO	Male	ASIAN	NOT HISPANIC OR LATINO	60.0	165.0	10	2012	7th	[Not Applicable]	YES	[Not Available]	[Not Available]	[Not Available]	TUMOR FREE	[Not Available]	[Not Available]	[Not Available]	CD20	Immunohistochemistry	Positive	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	None	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	40	[Not Applicable]	[Not Applicable]	[Not Applicable]	Stage II	0	[Not Available]	C83.3	9680/3	C17.1	YES	[Not Available]	Small Intestine	[Not Available]	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	FA	Small intestine	1:DECEASED	23.26	[Not Available]	[Not Available]
0BF573AC-CD1E-42D8-90CF-B30D7B08679C	TCGA-FA-A6HN	10/21/13	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	cervical	[Not Available]	[Not Available]	< or = 10%	Negative	No	No	YES	NO	Male	ASIAN	NOT HISPANIC OR LATINO	58.0	162.0	1.5	2013	7th	[Not Applicable]	NO	[Not Available]	[Not Available]	[Not Available]	TUMOR FREE	NO	[Not Available]	[Not Available]	CD20	Immunohistochemistry	Positive	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	None	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	73	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	0	[Not Available]	C83.3	9680/3	C77.0	YES	[Not Available]	Cervical lymph nodes	[Not Available]	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	FA	[Not Available]	1:DECEASED	1.91	[Not Available]	[Not Available]
69F23725-ADCA-48AC-9B33-80A7AAE24CFE	TCGA-FA-A6HO	10/21/13	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	cervical	[Not Available]	[Not Available]	< or = 10%	Negative	No	No	YES	NO	Female	ASIAN	NOT HISPANIC OR LATINO	61.0	158.0	1.5	2013	7th	[Not Applicable]	NO	[Not Available]	[Not Available]	[Not Available]	TUMOR FREE	NO	[Not Available]	[Not Available]	CD20	Immunohistochemistry	Positive	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	None	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	58	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	0	[Not Available]	C83.3	9680/3	C77.0	YES	[Not Available]	Cervical	[Not Available]	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	FA	[Not Available]	0:LIVING	24.61	1:Recurred/Progressed	24.28
ED746CB9-0F2F-48CE-923A-3A9F9F00B331	TCGA-FA-A7DS	11/13/13	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	other	[Not Available]	1	< or = 10%	Negative	No	No	YES	NO	Female	ASIAN	NOT HISPANIC OR LATINO	60.0	157.0	4	2013	7th	[Not Applicable]	NO	[Not Available]	[Not Available]	[Not Available]	TUMOR FREE	NO	[Not Available]	[Not Available]	CD20	Immunohistochemistry	Positive	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	None	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	54	[Not Applicable]	[Not Applicable]	[Not Applicable]	Stage II	0	[Not Available]	C50.9	9680/3	C50.9	YES	[Not Available]	Breast	[Not Available]	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	FA	Breast	0:LIVING	23.62	0:DiseaseFree	23.62
0030A28C-81AA-44B0-8BE0-B35E1DCBF98C	TCGA-FA-A7Q1	1/13/14	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	mesenteric	[Not Available]	[Not Available]	< or = 10%	Negative	No	No	YES	NO	Female	ASIAN	NOT HISPANIC OR LATINO	65.0	157.0	3	2013	7th	[Not Applicable]	NO	[Not Available]	[Not Available]	[Not Available]	TUMOR FREE	NO	[Not Available]	[Not Available]	CD20	Immunohistochemistry	Positive	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	None	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	Complete Remission/Response	NO	61	[Not Applicable]	[Not Applicable]	[Not Applicable]	Stage I	0	[Not Available]	C48.1	9680/3	C48.1	YES	[Not Available]	Mesenteric lymph nodes	[Not Available]	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	FA	[Not Available]	1:DECEASED	8.15	[Not Available]	[Not Available]
E6365B38-BC44-400C-B4AA-18CE8FF5BFCE	TCGA-FA-A82F	1/7/14	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	mesenteric	[Not Available]	1	< or = 10%	Negative	No	No	YES	NO	Female	ASIAN	NOT HISPANIC OR LATINO	50.0	157.0	6	2013	7th	[Not Applicable]	NO	[Not Available]	[Not Available]	[Not Available]	TUMOR FREE	NO	[Not Available]	[Not Available]	CD20|PAX5	Immunohistochemistry|Immunohistochemistry	Positive|Positive	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	None	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	48	[Not Applicable]	[Not Applicable]	[Not Applicable]	Stage II	0	[Not Available]	C83.3	9680/3	C17.9	YES	[Not Available]	Small Intestine	[Not Available]	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	FA	Small intestine	0:LIVING	14.03	0:DiseaseFree	14.03
B56BDBDB-43AF-4A03-A072-54DD22D7550C	TCGA-FA-A86F	1/3/14	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	Axillary	[Not Available]	[Not Available]	< or = 10%	Negative	No	No	YES	NO	Female	WHITE	NOT HISPANIC OR LATINO	67.0	156.0	2	2013	7th	[Not Applicable]	NO	[Not Available]	[Not Available]	[Not Available]	WITH TUMOR	NO	[Not Available]	[Not Available]	CD10 > 30%|CD20	Immunohistochemistry|Immunohistochemistry	Negative|Positive	26 - 50%	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	Partial Remission/Response	NO	64	[Not Applicable]	[Not Applicable]	[Not Applicable]	Stage III	0	[Not Available]	C83.3	9680/3	C77.3	YES	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	NO	FA	[Not Available]	0:LIVING	18.17	1:Recurred/Progressed	4.93
1f971af1-6772-4fe6-8d35-bbe527a037fe	TCGA-FF-8041	12/14/11	Primary mediastinal (thymic) DLBCL	mediastinal	[Not Available]	[Not Available]	< or = 10%	Negative	No	No	NO	YES	Female	ASIAN	NOT HISPANIC OR LATINO	58.9	173.0	12	2010	7th	[Not Applicable]	NO	0	499	380	TUMOR FREE	[Not Available]	NO	[Not Available]	CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|CD23|CD30|Cyclin D1	Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry	Negative|Positive|Positive|Positive|Positive|Negative|Positive|Negative	76 - 100%	[Not Available]	[Not Available]	[Not Available]	C-MYC|BCL2|BCL6|CCND1|MALT1	IGH|PAX5|[Not Available]|[Not Available]|[Not Available]	FISH|FISH|FISH|FISH|FISH	Normal|Normal|Normal|Normal|Normal	[Not Available]	[Not Available]	None	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	28	[Not Applicable]	[Not Applicable]	[Not Applicable]	Stage I	0	[Not Available]	C38.1	9680/3	C38.1	YES	[Not Available]	mediastinal	[Not Available]	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	FF	[Not Available]	0:LIVING	35.51	0:DiseaseFree	35.51
f0a326d2-1f3e-4a5d-bca8-32aaccc52338	TCGA-FF-8042	12/14/11	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	cervical|supraclavicular	[Not Available]	[Not Available]	< or = 10%	Negative	No	No	NO	YES	Female	ASIAN	NOT HISPANIC OR LATINO	89.9	171.0	1.5	2010	7th	[Not Applicable]	NO	0	461	380	TUMOR FREE	[Not Available]	NO	[Not Available]	CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|CD23|CD79a|CD5|Cyclin D1	Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry	Negative|Positive|Positive|Positive|Positive|Negative|Positive|Negative|Negative	76 - 100%	[Not Available]	[Not Available]	[Not Available]	C-MYC|BCL2|BCL6|CCND1|MALT1	PAX5|IGH|[Not Available]|[Not Available]|[Not Available]	FISH|FISH|FISH|FISH|FISH	Normal|Translocation|Normal|Normal|Normal	[Not Available]	[Not Available]	None	[Not Available]	Hepatitis B Virus	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	57	[Not Applicable]	[Not Applicable]	[Not Applicable]	Stage II	0	[Not Available]	C83.3	9680/3	C77.0	YES	[Not Available]	Supraclavicular lymph nodes	[Not Available]	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	FF	[Not Available]	0:LIVING	31.08	0:DiseaseFree	31.08
a8e2df1e-4042-42af-9231-3a00e83489f0	TCGA-FF-8043	12/14/11	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	mesenteric	[Not Available]	1	< or = 10%	Negative	No	No	NO	YES	Female	ASIAN	NOT HISPANIC OR LATINO	41.5	146.0	0.4	2010	7th	[Not Applicable]	YES	1	536	380	TUMOR FREE	[Not Available]	NO	[Not Available]	CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|CD5|Cyclin D1	Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry	Negative|Positive|Positive|Positive|Positive|Negative|Negative	76 - 100%	[Not Available]	[Not Available]	[Not Available]	C-MYC|BCL2|BCL6|CCND1|MALT1	PAX5|IGH|[Not Available]|[Not Available]|[Not Available]	FISH|FISH|FISH|FISH|FISH	Normal|Normal|Normal|Normal|Normal	[Not Available]	[Not Available]	None	[Not Available]	Hepatitis B Virus	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	70	[Not Applicable]	[Not Applicable]	[Not Applicable]	Stage II	0	[Not Available]	C83.3	9680/3	C18.9	YES	[Not Available]	Colon	[Not Available]	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	FF	Colon	0:LIVING	31.7	0:DiseaseFree	31.7
67325322-483f-443f-9ffa-2a20d108a2fb	TCGA-FF-8046	12/14/11	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	cervical|Submandibular	[Not Available]	[Not Available]	< or = 10%	Negative	No	No	YES	NO	Male	ASIAN	NOT HISPANIC OR LATINO	81.9	178.0	4.8	2011	7th	[Not Applicable]	NO	0	623	380	TUMOR FREE	[Not Available]	NO	[Not Available]	CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|Cyclin D1	Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry	Positive|Negative|Positive|Positive|Positive|Negative	76 - 100%	[Not Available]	[Not Available]	[Not Available]	C-MYC|BCL2|BCL6|CCND1|MALT1	PAX5|IGH|IGK|IGL|[Not Available]	FISH|FISH|FISH|FISH|FISH	Translocation|Normal|Normal|Normal|Normal	[Not Available]	[Not Available]	None	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	51	[Not Applicable]	[Not Applicable]	[Not Applicable]	Stage II	0	[Not Available]	C08.0	9680/3	C08.0	YES	[Not Available]	Thyroid	[Not Available]	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	FF	[Not Available]	0:LIVING	24.67	0:DiseaseFree	24.67
f978cb0f-d319-4c01-b4c5-23ae1403a106	TCGA-FF-8047	1/5/12	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	cervical|Inguinal	[Not Available]	[Not Available]	< or = 10%	Negative	No	No	YES	NO	Female	ASIAN	NOT HISPANIC OR LATINO	52.5	155.0	2	2011	7th	[Not Applicable]	NO	2	667	380	WITH TUMOR	[Not Available]	NO	[Not Available]	CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|Cyclin D1	Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry	Negative|Positive|Positive|Positive|Positive|Negative	76 - 100%	[Not Available]	[Not Available]	[Not Available]	C-MYC|BCL2|BCL6|CCND1|MALT1	PAX5|IGH|[Not Available]|[Not Available]|[Not Available]	FISH|FISH|FISH|FISH|FISH	Translocation|Normal|Translocation|Normal|Normal	[Not Available]	[Not Available]	None	[Not Available]	Hepatitis B Virus	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	38	[Not Applicable]	[Not Applicable]	[Not Applicable]	Stage II	0	[Not Available]	C83.3	9680/3	C77.0	YES	[Not Available]	Cervical	[Not Available]	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	FF	[Not Available]	0:LIVING	4.14	1:Recurred/Progressed	0.79
c8cde9ea-89e9-4ee8-8a46-417a48f6d3ab	TCGA-FF-8061	1/17/12	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	mesenteric	[Not Available]	1	< or = 10%	Negative	No	No	YES	NO	Male	ASIAN	NOT HISPANIC OR LATINO	48.1	171.0	15	2010	7th	[Not Applicable]	YES	0	414	380	TUMOR FREE	[Not Available]	NO	[Not Available]	CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|PAX5	Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry	Positive|Positive|Positive|Positive|Positive|Positive	76 - 100%	[Not Available]	[Not Available]	[Not Available]	C-MYC|BCL2|BCL6|CCND1|MALT1	PAX5|IGH|[Not Available]|[Not Available]|[Not Available]	FISH|FISH|FISH|FISH|FISH	Normal|Normal|Normal|Normal|Normal	[Not Available]	[Not Available]	None	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	42	[Not Applicable]	[Not Applicable]	[Not Applicable]	Stage II	0	[Not Available]	C83.3	9680/3	C17.9	YES	[Not Available]	Small Intestine	[Not Available]	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	FF	Small intestine	0:LIVING	27.33	0:DiseaseFree	27.33
0e9fcccc-0630-408d-a121-2c6413824cb7	TCGA-FF-8062	1/17/12	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	[Not Available]	[Not Available]	1	< or = 10%	Negative	No	No	YES	NO	Female	ASIAN	NOT HISPANIC OR LATINO	60.1	157.0	2	2011	7th	[Not Applicable]	YES	0	682	380	TUMOR FREE	[Not Available]	NO	[Not Available]	CD10 > 30%|BCL2|CD20|MUM1 > 30%|Cyclin D1	Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry	Positive|Negative|Positive|Negative|Negative	76 - 100%	[Not Available]	[Not Available]	[Not Available]	C-MYC|BCL2|BCL6|CCND1|MALT1	PAX5|IGH|IGK|IGL|[Not Available]	FISH|FISH|FISH|FISH|FISH	Normal|Normal|Normal|Normal|Normal	[Not Available]	[Not Available]	None	[Not Available]	Hepatitis B Virus	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	60	[Not Applicable]	[Not Applicable]	[Not Applicable]	Stage I	0	[Not Available]	C83.3	9680/3	C73.9	YES	[Not Available]	Thyroid	[Not Available]	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	FF	Thyroid	0:LIVING	22.31	0:DiseaseFree	22.31
F553F1A9-ECF2-4783-A609-6ADCA7C4C597	TCGA-FF-A7CQ	10/30/13	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	Axillary|cervical|hilar|Iliac-common|Iliac-external|mediastinal|mesenteric|para-aortic|retroperitoneal|Splenic	bladder	6	< or = 10%	Negative	No	No	NO	YES	Male	ASIAN	NOT HISPANIC OR LATINO	43.9	162.0	3.4	2010	7th	[Not Applicable]	YES	3	978	380	[Not Available]	YES	YES	Concordant Histology	CD10 > 30%|BCL2|CD20|MUM1 > 30%|CD138|CD15|Cyclin D1	Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry	Negative|Positive|Positive|Positive|Negative|Negative|Negative	51 - 75%	[Not Available]	[Not Available]	[Not Available]	C-MYC|BCL2|BCL6|MALT1	PAX 5|IGH|[Not Available]|[Not Available]	FISH|FISH|FISH|FISH	Normal|Amplification|Normal|Normal	[Not Available]	[Not Available]	None	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	Stable Disease	YES	74	[Not Applicable]	[Not Applicable]	[Not Applicable]	Stage IV	0	[Not Available]	C83.3	9680/3	C77.0	YES	[Not Available]	Paratracheal/Mediastinal	[Not Available]	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	YES	FF	Adrenal|Bone|Bone Marrow|Liver|Pleura/Pleural Effusion|Other Extranodal Site	0:LIVING	9.79	1:Recurred/Progressed	8.38
F784BC3A-751B-4025-AAB2-0AF2F6F24266	TCGA-FF-A7CR	10/30/13	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	Axillary|cervical|Inguinal|retroperitoneal	[Not Available]	2	< or = 10%	Negative	No	No	NO	YES	Male	ASIAN	NOT HISPANIC OR LATINO	73.0	170.0	3	2012	7th	[Not Applicable]	YES	0	446	380	WITH TUMOR	NO	NO	[Not Available]	CD10 > 30%|BCL2|CD20|MUM1 > 30%|CD138|BCL6 > 30%|CD23|CD5|CD30|EBER|Cyclin D1	Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry	Negative|Positive|Positive|Positive|Positive|Positive|Positive|Positive|Negative|Negative|Negative	0 - 25%	[Not Available]	[Not Available]	[Not Available]	C-MYC|BCL2|BCL6|CCND1|MALT1	PAX5|IGH|FoxP1|BCL10|[Not Available]	FISH|FISH|FISH|FISH|FISH	Normal|Normal|Normal|Normal|Normal	[Not Available]	[Not Available]	None	[Not Available]	Hepatitis C	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	Progressive Disease	YES	61	[Not Applicable]	[Not Applicable]	[Not Applicable]	Stage IV	0	[Not Available]	C83.3	9680/3	C77.0	YES	[Not Available]	Cervical lymph nodes	[Not Available]	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	YES	FF	Brain|Sinus	1:DECEASED	10.28	1:Recurred/Progressed	9.53
1D0DB5D7-39CA-466D-96B3-0D278C5EA768	TCGA-FF-A7CW	10/30/13	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	cervical	[Not Available]	1	< or = 10%	Negative	No	No	NO	YES	Male	ASIAN	NOT HISPANIC OR LATINO	51.0	154.0	2.1	2012	7th	[Not Applicable]	YES	0	426	380	TUMOR FREE	YES	NO	[Not Available]	CD10 > 30%|BCL2|CD20|MUM1 > 30%|CD138|BCL6 > 30%|CD30|EBER|Cyclin D1	Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry	Negative|Positive|Positive|Positive|Negative|Positive|Negative|Negative|Negative	51 - 75%	[Not Available]	[Not Available]	[Not Available]	C-MYC|BCL2|BCL6|MALT1	PAX5|IGH|[Not Available]|[Not Available]	FISH|FISH|FISH|FISH	Normal|Normal|Normal|Normal	[Not Available]	[Not Available]	None	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	Complete Remission/Response	NO	72	[Not Applicable]	[Not Applicable]	[Not Applicable]	Stage II	0	[Not Available]	C83.3	9680/3	C77.0	YES	[Not Available]	Supraclavicular lymph nodes	[Not Available]	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	YES	FF	Parotid Gland	0:LIVING	25.99	0:DiseaseFree	25.99
29E3D122-15A1-4235-A356-B1A9F94CEB39	TCGA-FF-A7CX	10/30/13	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	cervical	[Not Available]	4	< or = 10%	Negative	No	No	NO	YES	Male	ASIAN	NOT HISPANIC OR LATINO	66.0	174.0	2.4	2011	7th	[Not Applicable]	YES	0	714	380	TUMOR FREE	YES	NO	[Not Available]	CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|CD5|Cytoplasmic Ig|EBER|Cyclin D1	Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry	Negative|Positive|Positive|Positive|Positive|Negative|Positive|Negative|Negative	51 - 75%	[Not Available]	[Not Available]	[Not Available]	C-MYC|BCL2|BCL6|CCND1|MALT1	PAX 5|IGH|BCL10|[Not Available]|[Not Available]	FISH|FISH|FISH|FISH|FISH	Normal|Normal|Normal|Normal|Normal	[Not Available]	[Not Available]	None	[Not Available]	[Not Available]	[Not Available]	negative	[Not Available]	EBER in situ hybridization	NO	[Not Available]	Complete Remission/Response	NO	46	[Not Applicable]	[Not Applicable]	[Not Applicable]	Stage IV	0	[Not Available]	C49.0	9680/3	C49.0	YES	[Not Available]	Lung	[Not Available]	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	YES	FF	Adrenal|Soft Tissue (muscle  ligaments  subcutaneous)|Brain|Thyroid|Lung	0:LIVING	12.65	0:DiseaseFree	12.65
e56e4d9c-052e-4ec6-a81b-dbd53e9c8ffe	TCGA-FM-8000	5/16/12	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	[Not Available]	[Not Available]	2	< or = 10%	Negative	No	No	YES	NO	Female	WHITE	NOT HISPANIC OR LATINO	69.5	155.0	12	2011	7th	[Not Applicable]	YES	[Not Available]	321	260	TUMOR FREE	[Not Available]	NO	Discordant Histology	CD19|CD10 > 30%|CD20|MUM1 > 30%|BCL6 > 30%|CD23|PAX5|CD5|Cyclin D1	Flow cytometry|Immunohistochemistry|Flow cytometry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry	Positive|Negative|Positive|Negative|Positive|Positive|Positive|Positive|Negative	26 - 50%	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Other	Diverticulitis requiring colectomy	None	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	70	[Not Applicable]	[Not Applicable]	[Not Applicable]	Stage II	0	[Not Available]	C83.3	9680/3	C18.9	YES	[Not Available]	Colon	[Not Available]	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	FM	Colon|Small intestine	0:LIVING	31.93	0:DiseaseFree	31.93
6a21c948-cd85-4150-8c01-83017d7dc1ed	TCGA-G8-6324	4/20/12	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	mesenteric	[Not Available]	1	[Not Available]	Negative	No	No	NO	YES	Female	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	60.0	165.5	[Not Available]	2006	6th	[Not Applicable]	YES	1	498	618	WITH TUMOR	[Not Available]	YES	Discordant Histology	CD19|CD10 > 30%|BCL2|CD20|CD20|MUM1 > 30%|BCL6 > 30%|CD23|CD23|PAX5|CD5|CD5	Flow cytometry|Flow cytometry|Immunohistochemistry|Immunohistochemistry|Flow cytometry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Flow cytometry|Immunohistochemistry|Immunohistochemistry|Flow cytometry	Positive|Negative|Positive|Positive|Positive|Positive|Positive|Positive|Positive|Positive|Negative|Negative	51 - 75%	IgH PCR	Clonal	[Not Available]	BCL2|BCL6|CCND1	[Not Available]|[Not Available]|[Not Available]	FISH|FISH|FISH	Normal|Normal|Normal	[Not Available]	[Not Available]	None	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	43	[Not Applicable]	[Not Applicable]	[Not Applicable]	Stage IV	0	[Not Available]	C83.3	9680/3	C77.2	YES	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	G8	Ascites/Peritoneum	1:DECEASED	41.13	1:Recurred/Progressed	11.1
ea54dbad-1b23-41cc-9378-d4002a8fca51	TCGA-G8-6325	4/18/12	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	retroperitoneal	[Not Available]	0	[Not Available]	Negative	No	No	NO	YES	Male	WHITE	NOT HISPANIC OR LATINO	105.7	171.0	[Not Available]	2008	6th	[Not Applicable]	NO	1	[Not Available]	618	TUMOR FREE	[Not Available]	NO	[Not Available]	CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|CD30	Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry	Negative|Positive|Positive|Positive|Positive|Negative	51 - 75%	IgH PCR	Clonal	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Rheumatoid Arthritis|Other	Non-insulin dependent diabetes mellitus	Methotrexate	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	69	[Not Applicable]	[Not Applicable]	[Not Applicable]	Stage IV	0	[Not Available]	C83.3	9680/3	C77.2	YES	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	G8	[Not Available]	0:LIVING	51.94	0:DiseaseFree	51.94
f8cf647b-1447-4ac3-8c43-bef07765cabf	TCGA-G8-6326	4/16/12	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	mesenteric	Omentum	2	[Not Available]	Negative	No	No	NO	YES	Male	WHITE	NOT HISPANIC OR LATINO	127.7	185.0	[Not Available]	2009	6th	[Not Applicable]	YES	0	964	618	TUMOR FREE	[Not Available]	YES	Concordant Histology	CD10 > 30%|CD20|BCL6 > 30%|MUM1 > 30%|CD23|CD79a|PAX5|CD5|CD30|CD15|ALK	Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry	Negative|Positive|Positive|Negative|Negative|Positive|Positive|Negative|Negative|Negative|Negative	[Not Available]	IgH PCR	Clonal	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	None	[Not Available]	[Not Available]	[Not Available]	negative	[Not Available]	EBER in situ hybridization	[Not Available]	[Not Available]	[Not Available]	[Not Available]	52	[Not Applicable]	[Not Applicable]	[Not Applicable]	Stage IV	0	[Not Available]	C48.1	9680/3	C48.1	YES	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	G8	Ascites/Peritoneum|Other Extranodal Site	0:LIVING	70.01	0:DiseaseFree	70.01
3f5a897d-1eaa-4d4c-8324-27ac07c90927	TCGA-G8-6906	5/16/12	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	para-aortic|retroperitoneal	Spleen	1	[Not Available]	Negative	No	Yes	NO	YES	Male	WHITE	NOT HISPANIC OR LATINO	59.2	164.3	[Not Available]	1987	[Not Available]	[Not Applicable]	YES	[Not Available]	325	185	TUMOR FREE	[Not Available]	NO	[Not Available]	CD19|CD10 > 30%|BCL2	Flow cytometry|Flow cytometry|Immunohistochemistry	Positive|Negative|Positive	[Not Available]	IgH Southern Blot	Non-Clonal	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	58	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	0	[Not Available]	C83.3	9680/3	C77.2	YES	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	G8	Other Extranodal Site	1:DECEASED	211.07	1:Recurred/Progressed	209.69
31bbad4e-3789-42ec-9faa-1cb86970f723	TCGA-G8-6907	5/17/12	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	cervical	[Not Available]	0	[Not Available]	Negative	No	No	NO	YES	Female	WHITE	NOT HISPANIC OR LATINO	91.8	154.2	[Not Available]	2000	5th	[Not Applicable]	NO	[Not Available]	628	618	WITH TUMOR	YES	NO	[Not Available]	CD10 > 30%|BCL2|CD20|CD23|CD5	Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry	Positive|Positive|Positive|Negative|Negative	[Not Available]	IgH Southern Blot	Non-Clonal	[Not Available]	BCL2	[Not Available]	PCR	Normal	[Not Available]	[Not Available]	None	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	Stable Disease	YES	57	[Not Applicable]	[Not Applicable]	[Not Applicable]	Stage IV	0	[Not Available]	C83.3	9680/3	C77.0	YES	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	YES	G8	[Not Available]	1:DECEASED	19.55	1:Recurred/Progressed	9.17
a468e725-ad4b-411d-ac5c-2eacc68ec580	TCGA-G8-6909	4/5/12	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	mediastinal	[Not Available]	0	[Not Available]	Negative	No	No	NO	YES	Male	WHITE	NOT HISPANIC OR LATINO	90.5	178.0	[Not Available]	2002	5th	[Not Applicable]	NO	0	[Not Available]	[Not Available]	TUMOR FREE	[Not Available]	NO	[Not Available]	CD10 > 30%|BCL2|CD20|BCL6 > 30%|CD23|CD5|CD30	Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry	Negative|Negative|Positive|Negative|Negative|Negative|Negative	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	None	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	67	[Not Applicable]	[Not Applicable]	[Not Applicable]	Stage III	0	[Not Available]	C77.1	9680/3	C77.1	YES	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	G8	[Not Available]	1:DECEASED	116.72	[Not Available]	[Not Available]
3622cf29-600f-4410-84d4-a9afeb41c475	TCGA-G8-6914	4/4/12	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	cervical	[Not Available]	[Not Available]	[Not Available]	Negative	No	No	NO	YES	Male	WHITE	NOT HISPANIC OR LATINO	72.5	172.0	[Not Available]	1996	4th	[Not Applicable]	NO	[Not Available]	[Not Available]	[Not Available]	TUMOR FREE	[Not Available]	NO	[Not Available]	CD19|CD20|CD22	Flow cytometry|Flow cytometry|Flow cytometry	Positive|Positive|Positive	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	None	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	67	[Not Applicable]	[Not Applicable]	[Not Applicable]	Stage III	0	[Not Available]	C83.3	9680/3	C77.0	YES	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	G8	[Not Available]	0:LIVING	196.45	1:Recurred/Progressed	120.53
7a589441-11ef-4158-87e7-3951d86bc2aa	TCGA-GR-7351	7/3/12	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	[Not Available]	[Not Available]	1	< or = 10%	[Not Available]	No	No	NO	YES	Female	WHITE	NOT HISPANIC OR LATINO	77.5	166.5	5.5	2001	[Not Available]	[Not Applicable]	YES	1	498	618	TUMOR FREE	YES	NO	[Not Available]	CD10 > 30%|CD20|BCL6 > 30%	Immunohistochemistry|Immunohistochemistry|Immunohistochemistry	Positive|Positive|Positive	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Hashimoto's Thyroiditis	[Not Available]	None	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	[Not Available]	Complete Remission/Response	NO	56	[Not Applicable]	[Not Applicable]	[Not Applicable]	Stage I	0	[Not Available]	C83.3	9680/3	C73.9	YES	[Not Available]	Thyroid	[Not Available]	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	YES	GR	Thyroid	0:LIVING	150.39	0:DiseaseFree	150.39
c3d662ee-48d0-454a-bb0c-77d3338d3747	TCGA-GR-7353	7/3/12	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	cervical	[Not Available]	0	< or = 10%	[Not Available]	No	No	NO	YES	Male	WHITE	NOT HISPANIC OR LATINO	68.0	171.5	4.4	2005	[Not Available]	[Not Applicable]	NO	1	164	250	TUMOR FREE	YES	NO	[Not Available]	CD10 > 30%|BCL2|CD20|BCL6 > 30%|CD5|Cyclin D1	Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry	Positive|Negative|Positive|Positive|Negative|Negative	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	Complete Remission/Response	NO	36	[Not Applicable]	[Not Applicable]	[Not Applicable]	Stage II	0	[Not Available]	C83.3	9680/3	C77.0	YES	[Not Available]	Cervical lymph nodes	[Not Available]	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	YES	GR	[Not Available]	0:LIVING	98.0	0:DiseaseFree	98
D7DF78B5-24F1-4FF4-BD9B-F0E6BEC8289A	TCGA-GR-A4D4	1/10/13	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	[Not Available]	[Not Available]	2	< or = 10%	[Not Available]	No	No	NO	YES	Female	WHITE	NOT HISPANIC OR LATINO	76.1	168.0	5.4	2010	[Not Available]	[Not Applicable]	YES	2	143	192	TUMOR FREE	YES	NO	[Not Available]	CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|PAX5|CD5|CD30|EBER|ALK	Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry	Positive|Positive|Positive|Negative|Positive|Positive|Negative|Negative|Negative|Negative	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	Complete Remission/Response	NO	57	[Not Applicable]	[Not Applicable]	[Not Applicable]	Stage IV	0	[Not Available]	C83.3	9680/3	C49.9	YES	[Not Available]	Soft Tissue (muscle, ligaments, subcutaneous)	[Not Available]	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	YES	GR	Bone|Soft Tissue (muscle  ligaments  subcutaneous)	0:LIVING	51.94	0:DiseaseFree	51.94
F855DAD1-6FFC-493E-BA6C-970874BC9210	TCGA-GR-A4D5	1/9/13	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	Axillary|cervical|Inguinal|mesenteric|supraclavicular	[Not Available]	3	< or = 10%	Negative	No	No	NO	YES	Female	WHITE	NOT HISPANIC OR LATINO	117.1	159.5	4.5	2010	[Not Available]	[Not Applicable]	YES	1	851	618	TUMOR FREE	YES	NO	[Not Available]	CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|CD5|CD30|CD15	Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry	Negative|Positive|Positive|Positive|Positive|Negative|Positive|Negative	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	Complete Remission/Response	NO	46	[Not Applicable]	[Not Applicable]	[Not Applicable]	Stage IV	0	[Not Available]	C83.3	9680/3	C77.0	YES	[Not Available]	Cervical lymph nodes	[Not Available]	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	YES	GR	Bone|Skin|Soft Tissue (muscle  ligaments  subcutaneous)	0:LIVING	42.67	0:DiseaseFree	42.67
C1C06604-5AE2-4A53-B9C0-EB210D38E3F0	TCGA-GR-A4D6	1/9/13	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	cervical	[Not Available]	0	< or = 10%	[Not Available]	No	No	NO	YES	Female	ASIAN	NOT HISPANIC OR LATINO	54.5	155.0	2.7	2010	[Not Available]	[Not Applicable]	NO	0	120	192	TUMOR FREE	YES	NO	[Not Available]	CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|CD5	Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry	Positive|Positive|Positive|Positive|Positive|Negative	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	Complete Remission/Response	NO	54	[Not Applicable]	[Not Applicable]	[Not Applicable]	Stage I	0	[Not Available]	C83.3	9680/3	C77.0	YES	[Not Available]	Cervical lymph nodes	[Not Available]	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	YES	GR	[Not Available]	0:LIVING	43.82	0:DiseaseFree	43.82
5EFF68FF-F6C3-40C9-9FC8-00E684A7B712	TCGA-GR-A4D9	1/10/13	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	Axillary|cervical|hilar|Iliac-common|Iliac-external|Inguinal|mediastinal|retroperitoneal|supraclavicular	[Not Available]	3	< or = 10%	[Not Available]	No	No	NO	YES	Female	WHITE	NOT HISPANIC OR LATINO	96.8	164.7	7	2009	[Not Available]	[Not Applicable]	YES	1	420	618	[Not Available]	YES	NO	[Not Available]	CD19|CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|CD23|CD5|EBER	Flow cytometry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Flow cytometry|Immunohistochemistry|Immunohistochemistry	Positive|Negative|Negative|Positive|Positive|Positive|Negative|Negative|Negative	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Other	Common variable immunodeficiency	Other	Immunoglobulin	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	Complete Remission/Response	YES	66	[Not Applicable]	[Not Applicable]	[Not Applicable]	Stage IV	0	[Not Available]	C83.3	9680/3	C77.0	YES	[Not Available]	Cervical lymph nodes	[Not Available]	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	YES	GR	Soft Tissue (muscle  ligaments  subcutaneous)|Lung|Pleura/Pleural Effusion	0:LIVING	57.13	1:Recurred/Progressed	40.01
45B0CF9F-A879-417F-8F39-7770552252C0	TCGA-GS-A9TQ	6/2/14	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	Femoral|Inguinal	[Not Available]	0	< or = 10%	Negative	No	No	NO	YES	Female	WHITE	HISPANIC OR LATINO	68.0	155.0	3	2012	7th	[Not Applicable]	NO	1	364	450	TUMOR FREE	YES	NO	[Not Available]	CD10 > 30%|BCL2|CD20|CD138|CD22|BCL6 > 30%|CD23|CD79a|CD5|CD19|P53 >20%|MUM1 > 30%|Cytoplasmic Ig|Surface Ig	Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Flow cytometry|Flow cytometry|Immunohistochemistry|Flow cytometry|Immunohistochemistry|Flow cytometry|Flow cytometry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Flow cytometry	Positive|Positive|Positive|Negative|Positive|Positive|Positive|Positive|Negative|Positive|Negative|Negative|Indeterminate|Positive	76 - 100%	[Not Available]	[Not Available]	[Not Available]	C-MYC	[Not Available]	FISH	Gain	[Not Available]	[Not Available]	None	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	Complete Remission/Response	NO	69	[Not Applicable]	[Not Applicable]	[Not Applicable]	Stage II	0	[Not Available]	C83.3	9680/3	C77.4	YES	[Not Available]	Inguinal	[Not Available]	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	YES	GS	[Not Available]	0:LIVING	32.26	0:DiseaseFree	32.26
33365D22-CB83-4D8E-A2D1-06B675F75F6E	TCGA-GS-A9TT	6/2/14	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	Axillary|para-aortic|Splenic|supraclavicular	[Not Available]	2	< or = 10%	Negative	No	No	NO	YES	Male	WHITE	HISPANIC OR LATINO	85.0	169.0	3	2011	7th	[Not Applicable]	YES	1	756	450	TUMOR FREE	YES	NO	[Not Available]	CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|CD23|CD79a|CD5|CD19|CD22|Cytoplasmic Ig|Surface Ig|EBER	Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Flow cytometry|Immunohistochemistry|Flow cytometry|Flow cytometry|Flow cytometry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry	Negative|Positive|Positive|Positive|Negative|Positive|Positive|Negative|Positive|Positive|Positive|Positive|Negative	76 - 100%	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	None	[Not Available]	[Not Available]	[Not Available]	negative	[Not Available]	EBER in situ hybridization	NO	[Not Available]	Complete Remission/Response	NO	70	[Not Applicable]	[Not Applicable]	[Not Applicable]	Stage IV	0	[Not Available]	C62.90	9680/3	C62.9	YES	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	YES	GS	Bone|Testes	0:LIVING	38.21	0:DiseaseFree	38.21
1EA575F1-F731-408B-A629-F5F4ABAB569E	TCGA-GS-A9TU	6/2/14	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	Inguinal	[Not Available]	0	< or = 10%	Negative	No	No	NO	YES	Male	WHITE	HISPANIC OR LATINO	90.0	183.0	2	2004	6th	[Not Applicable]	NO	1	337	450	TUMOR FREE	NO	[Not Available]	[Not Available]	CD19|CD10 > 30%|BCL2|P53 >20%|CD20|MUM1 > 30%|CD22|BCL6 > 30%|CD23|CD79a|CD5|Cytoplasmic Ig	Flow cytometry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Flow cytometry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry	Positive|Negative|Positive|Negative|Positive|Positive|Positive|Positive|Negative|Positive|Negative|Positive	51 - 75%	IgH PCR	Non-Clonal	[Not Available]	BCL2	[Not Available]	PCR	Normal	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	Complete Remission/Response	NO	45	[Not Applicable]	[Not Applicable]	[Not Applicable]	Stage II	0	[Not Available]	C83.3	9680/3	C77.4	YES	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	YES	GS	[Not Available]	0:LIVING	128.02	0:DiseaseFree	128.02
C85F340E-584B-4F3B-B6A5-540491FC8AD2	TCGA-GS-A9TV	6/2/14	Primary mediastinal (thymic) DLBCL	cervical|mediastinal|para-aortic|supraclavicular	[Not Available]	0	< or = 10%	Negative	No	No	NO	YES	Female	WHITE	HISPANIC OR LATINO	58.0	160.0	5	2013	7th	[Not Applicable]	NO	0	[Not Available]	450	TUMOR FREE	YES	NO	[Not Available]	CD20|CD23|PAX5|CD30|CD15|EBER|CD5|Cytoplasmic Ig|Surface Ig	Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Flow cytometry	Positive|Positive|Positive|Positive|Negative|Negative|Negative|Indeterminate|Indeterminate	26 - 50%	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	negative	[Not Available]	EBER in situ hybridization	NO	[Not Available]	Complete Remission/Response	NO	40	[Not Applicable]	[Not Applicable]	[Not Applicable]	Stage II	0	[Not Available]	C83.3	9680/3	C77.0	YES	[Not Available]	mediastinal	[Not Available]	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	YES	GS	[Not Available]	0:LIVING	23.98	0:DiseaseFree	23.98
29AFF186-C321-4FF9-B81B-105E27E620FF	TCGA-GS-A9TW	6/2/14	Primary mediastinal (thymic) DLBCL	Axillary|cervical|mediastinal|para-aortic	[Not Available]	0	< or = 10%	Negative	No	No	NO	YES	Female	WHITE	HISPANIC OR LATINO	54.0	165.0	4	2010	7th	[Not Applicable]	NO	0	252	450	TUMOR FREE	YES	NO	[Not Available]	CD10 > 30%|BCL2|CD20|BCL6 > 30%|CD79a|CD30|CD15|EBER|CD5|Cytoplasmic Ig|Surface Ig	Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Flow cytometry	Negative|Positive|Positive|Positive|Positive|Positive|Negative|Negative|Negative|Indeterminate|Indeterminate	76 - 100%	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	negative	[Not Available]	EBER in situ hybridization	NO	[Not Available]	Complete Remission/Response	NO	23	[Not Applicable]	[Not Applicable]	[Not Applicable]	Stage II	0	[Not Available]	C83.3	9680/3	C77.3	YES	[Not Available]	mediastinal	[Not Available]	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	YES	GS	[Not Available]	0:LIVING	53.12	0:DiseaseFree	53.12
58E66976-4507-4552-AC53-83A49A142DDE	TCGA-GS-A9TX	6/2/14	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	Inguinal	[Not Available]	0	< or = 10%	Negative	No	No	NO	YES	Male	WHITE	HISPANIC OR LATINO	85.0	187.0	0.42	2011	7th	[Not Applicable]	NO	0	257	450	TUMOR FREE	YES	NO	[Not Available]	CD19|CD10 > 30%|BCL2|P53 >20%|CD20|CD22|BCL6 > 30%|CD23|CD79a|CD5|CD30|Cytoplasmic Ig|Surface Ig	Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Flow cytometry|Immunohistochemistry|Flow cytometry	Positive|Positive|Negative|Negative|Positive|Positive|Positive|Positive|Positive|Negative|Negative|Positive|Positive	51 - 75%	[Not Available]	[Not Available]	[Not Available]	BCL2|BCL6	1p36|[Not Available]	FISH|FISH	Normal|Gain	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	Complete Remission/Response	NO	37	[Not Applicable]	[Not Applicable]	[Not Applicable]	Stage I	0	[Not Available]	C83.3	9680/3	C77.4	YES	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	YES	GS	[Not Available]	0:LIVING	45.11	0:DiseaseFree	45.11
6E9437F0-A4ED-475C-AB0E-BF1431C70A90	TCGA-GS-A9TY	6/2/14	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	Axillary	[Not Available]	0	< or = 10%	Negative	No	No	NO	YES	Female	WHITE	HISPANIC OR LATINO	77.0	153.0	1	2005	6th	[Not Applicable]	NO	1	288	450	TUMOR FREE	NO	[Not Available]	[Not Available]	CD10 > 30%|BCL2|P53 >20%|CD20|MUM1 > 30%|BCL6 > 30%|CD5|Cytoplasmic Ig	Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry	Negative|Negative|Positive|Positive|Negative|Positive|Negative|Indeterminate	51 - 75%	[Not Available]	[Not Available]	[Not Available]	BCL2	[Not Available]	PCR	Normal	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	Complete Remission/Response	NO	82	[Not Applicable]	[Not Applicable]	[Not Applicable]	Stage I	0	[Not Available]	C83.3	9680/3	C77.3	YES	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	YES	GS	[Not Available]	0:LIVING	109.49	1:Recurred/Progressed	106.93
EDA9496E-BE80-4A13-BF06-89F0CC9E937F	TCGA-GS-A9TZ	6/2/14	Primary mediastinal (thymic) DLBCL	cervical|mediastinal|supraclavicular	[Not Available]	0	< or = 10%	Negative	No	No	NO	YES	Male	WHITE	HISPANIC OR LATINO	68.0	168.0	17	2012	7th	[Not Applicable]	NO	0	[Not Available]	450	TUMOR FREE	YES	NO	[Not Available]	CD19|CD10 > 30%|BCL2|CD20|MUM1 > 30%|CD22|BCL6 > 30%|CD23|CD79a|CD5|CD15|EBER|CD30|Cytoplasmic Ig|Surface Ig	Flow cytometry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Flow cytometry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Flow cytometry	Positive|Negative|Positive|Positive|Positive|Positive|Positive|Positive|Positive|Negative|Negative|Negative|Positive|Indeterminate|Indeterminate	51 - 75%	[Not Available]	[Not Available]	[Not Available]	[Not Available]	G Band Karyotype	Cytogenetics	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	negative	[Not Available]	EBER in situ hybridization	NO	[Not Available]	Partial Remission/Response	NO	51	[Not Applicable]	[Not Applicable]	[Not Applicable]	Stage II	0	[Not Available]	C83.3	9680/3	C77.0	YES	[Not Available]	mediastinal	[Not Available]	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	YES	GS	[Not Available]	0:LIVING	25.13	0:DiseaseFree	25.13
FDECB74F-AC4E-46B1-B23A-5F7FDE96EF9F	TCGA-GS-A9U3	6/2/14	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	hilar|Iliac-common|Inguinal|para-aortic|Splenic	[Not Available]	[Not Available]	< or = 10%	Negative	No	No	NO	YES	Female	WHITE	HISPANIC OR LATINO	80.0	157.0	3	2005	6th	[Not Applicable]	NO	1	391	450	TUMOR FREE	YES	NO	[Not Available]	CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|CD22|CD5|CD30|Cytoplasmic Ig|Surface Ig	Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Flow cytometry|Immunohistochemistry|Flow cytometry|Immunohistochemistry|Flow cytometry	Negative|Positive|Positive|Negative|Negative|Positive|Negative|Negative|Positive|Positive	51 - 75%	[Not Available]	[Not Available]	[Not Available]	BCL2	[Not Available]	PCR	Translocation	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	Complete Remission/Response	NO	77	[Not Applicable]	[Not Applicable]	[Not Applicable]	Stage III	0	[Not Available]	C83.3	9680/3	C77.4	YES	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	YES	GS	[Not Available]	0:LIVING	111.5	0:DiseaseFree	111.5
0E251C03-BF86-4ED8-B45D-3CBC97160502	TCGA-GS-A9U4	6/2/14	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	supraclavicular|Submandibular	[Not Available]	0	< or = 10%	Negative	No	No	NO	YES	Female	WHITE	HISPANIC OR LATINO	50.0	163.0	3	2011	7th	[Not Applicable]	NO	0	385	450	WITH TUMOR	YES	NO	[Not Available]	CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|CD79a|CD5|CD30|CD15|EBER|ALK|Cytoplasmic Ig	Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry	Negative|Positive|Positive|Positive|Negative|Positive|Negative|Positive|Negative|Positive|Negative|Indeterminate	51 - 75%	IgH PCR	Clonal	[Not Available]	C-MYC	[Not Available]	FISH	Loss	Other	Behget's disease	Azathioprine|Other	Prednisone	[Not Available]	[Not Available]	positive	80	EBER in situ hybridization	NO	[Not Available]	Progressive Disease	YES	27	[Not Applicable]	[Not Applicable]	[Not Applicable]	Stage II	0	[Not Available]	C83.3	9680/3	C77.0	YES	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	YES	GS	[Not Available]	1:DECEASED	12.84	1:Recurred/Progressed	3.48
25FF86AF-BEB4-480C-B706-F3FE0306F7CF	TCGA-RQ-A68N	12/12/13	Primary DLBCL of the CNS	other	[Not Available]	3	< or = 10%	[Not Available]	No	No	NO	YES	Male	WHITE	HISPANIC OR LATINO	58.0	162.0	[Not Available]	2012	7th	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	TUMOR FREE	YES	NO	[Not Available]	CD10 > 30%|BCL2|CD20	Immunohistochemistry|Immunohistochemistry|Immunohistochemistry	Negative|Positive|Positive	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	Partial Remission/Response	NO	63	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	0	[Not Available]	C71.7	9680/3	C71.7	YES	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	YES	RQ	Brain	0:LIVING	25.89	0:DiseaseFree	25.89
DC87A809-95DE-4EB7-A1C2-2650475F2D7E	TCGA-RQ-A6JB	11/14/14	Primary DLBCL of the CNS	other	[Not Available]	3	< or = 10%	Negative	No	No	NO	YES	Female	WHITE	NOT HISPANIC OR LATINO	72.0	167.0	[Not Available]	2011	7th	[Not Applicable]	YES	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	None	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	62	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	0	[Not Available]	C83.3	9680/3	C41.0	YES	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	RQ	Bone|Skin|Soft Tissue (muscle  ligaments  subcutaneous)	0:LIVING	0.03	0:DiseaseFree	0.03
4DD86EBD-EF16-4B2B-9EA0-5D1D7AFEF257	TCGA-RQ-AAAT	7/28/14	Primary DLBCL of the CNS	other	[Not Available]	1	< or = 10%	Negative	No	No	NO	YES	Female	WHITE	HISPANIC OR LATINO	68.2	162.5	1.8	2013	7th	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	TUMOR FREE	[Not Available]	[Not Available]	[Not Available]	CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|CD30|[Not Available]	Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|[Not Available]	Positive|Negative|Positive|Positive|Positive|Negative|[Not Available]	76 - 100%	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	Complete Remission/Response	NO	63	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	0	[Not Available]	C71.6	9680/3	C71.6	YES	[Not Available]	Posterior Fossa	[Not Available]	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	NO	RQ	Brain	0:LIVING	0.56	0:DiseaseFree	0.56
A6923479-4E68-4EA8-87ED-E9642B9D43D5	TCGA-VB-A8QN	2/15/15	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	other	[Not Available]	[Not Available]	[Not Available]	Negative	No	No	YES	NO	Male	WHITE	NOT HISPANIC OR LATINO	75.0	180.0	10	2013	7th	[Not Applicable]	YES	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	None	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	55	[Not Applicable]	[Not Applicable]	[Not Applicable]	Stage III	0	[Not Available]	C83.3	9680/3	C16.9	YES	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	NO	VB	Stomach	0:LIVING	0.0	0:DiseaseFree	0
